NovaBay Pharmaceuticals Statistics
Total Valuation
NBY has a market cap or net worth of $3.32 million. The enterprise value is $4.56 million.
Important Dates
The next estimated earnings date is Thursday, May 8, 2025, after market close.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NBY has 5.82 million shares outstanding. The number of shares has increased by 2,730.00% in one year.
| Current Share Class | 5.82M |
| Shares Outstanding | 5.82M |
| Shares Change (YoY) | +2,730.00% |
| Shares Change (QoQ) | +115.50% |
| Owned by Insiders (%) | 0.01% |
| Owned by Institutions (%) | 2.95% |
| Float | 4.80M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.20 |
| Forward PS | 0.27 |
| PB Ratio | -25.71 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.47 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.68
| Current Ratio | 0.68 |
| Quick Ratio | 0.29 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.50 |
Financial Efficiency
Return on equity (ROE) is -452.75% and return on invested capital (ROIC) is -83.23%.
| Return on Equity (ROE) | -452.75% |
| Return on Assets (ROA) | -49.91% |
| Return on Invested Capital (ROIC) | -83.23% |
| Return on Capital Employed (ROCE) | -857.59% |
| Revenue Per Employee | $698,643 |
| Profits Per Employee | -$614,857 |
| Employee Count | 14 |
| Asset Turnover | 1.57 |
| Inventory Turnover | 5.21 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -78.92% in the last 52 weeks. The beta is 0.90, so NBY's price volatility has been similar to the market average.
| Beta (5Y) | 0.90 |
| 52-Week Price Change | -78.92% |
| 50-Day Moving Average | 0.60 |
| 200-Day Moving Average | 0.70 |
| Relative Strength Index (RSI) | 50.73 |
| Average Volume (20 Days) | 65,795 |
Short Selling Information
The latest short interest is 32,698, so 0.56% of the outstanding shares have been sold short.
| Short Interest | 32,698 |
| Short Previous Month | 88,956 |
| Short % of Shares Out | 0.56% |
| Short % of Float | 0.68% |
| Short Ratio (days to cover) | 0.60 |
Income Statement
In the last 12 months, NBY had revenue of $9.78 million and -$8.61 million in losses. Loss per share was -$2.53.
| Revenue | 9.78M |
| Gross Profit | 6.48M |
| Operating Income | -4.97M |
| Pretax Income | -11.12M |
| Net Income | -8.61M |
| EBITDA | -4.93M |
| EBIT | -4.97M |
| Loss Per Share | -$2.53 |
Full Income StatementBalance Sheet
The company has $430,000 in cash and $1.67 million in debt, giving a net cash position of -$1.24 million or -$0.21 per share.
| Cash & Cash Equivalents | 430,000 |
| Total Debt | 1.67M |
| Net Cash | -1.24M |
| Net Cash Per Share | -$0.21 |
| Equity (Book Value) | -129,000 |
| Book Value Per Share | -0.03 |
| Working Capital | -908,000 |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$5.39 million and capital expenditures -$6,000, giving a free cash flow of -$5.40 million.
| Operating Cash Flow | -5.39M |
| Capital Expenditures | -6,000 |
| Free Cash Flow | -5.40M |
| FCF Per Share | -$0.93 |
Full Cash Flow StatementMargins
Gross margin is 66.26%, with operating and profit margins of -50.85% and -73.85%.
| Gross Margin | 66.26% |
| Operating Margin | -50.85% |
| Pretax Margin | -73.71% |
| Profit Margin | -73.85% |
| EBITDA Margin | -50.44% |
| EBIT Margin | -50.85% |
| FCF Margin | n/a |
Dividends & Yields
NBY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2,730.00% |
| Shareholder Yield | -2,730.00% |
| Earnings Yield | -259.56% |
| FCF Yield | -162.68% |
Analyst Forecast
The average price target for NBY is $0.85, which is 49.07% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $0.85 |
| Price Target Difference | 49.07% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on May 31, 2024. It was a reverse split with a ratio of 0.028571429:1.
| Last Split Date | May 31, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.028571429:1 |
Scores
NBY has an Altman Z-Score of -76.85 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -76.85 |
| Piotroski F-Score | 3 |